DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Halozyme Therapeutics
HALO
Teradata Corp
TDC
Cars.com
CARS
Collegium Pharmaceutical
COLL
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 2,188.95%14.94M | -95.79%193K | 24.34%8.81M | -4.51%17.91M | 12.48%6.96M | -112.72%-715K | 36.19%4.59M | 97.55%7.08M | 33.99%18.76M | 443.76%6.19M |
Net income from continuing operations | 71.41%9.1M | 730.94%7.65M | 8.91%8.38M | 594.52%20.14M | 231.15%6.22M | 104.15%5.31M | 395.16%921K | 58.46%7.7M | -76.16%2.9M | -461.48%-4.74M |
Depreciation and amortization | 263.84%1.8M | 237.71%1.62M | 14.50%624K | -70.00%2.09M | -59.46%568K | -72.19%495K | -75.41%480K | -70.15%545K | 189.84%6.96M | 133.50%1.4M |
Other non cash items | 114.34%501K | -606.95%-6.49M | -137.26%-490K | -88.28%1.06M | -77.66%1.96M | -381.47%-3.49M | 431.61%1.28M | 327.12%1.32M | 1,386.18%9.03M | 1,516.02%8.75M |
Change In working capital | 148.65%2.12M | -239.65%-3.4M | 82.34%-720K | -124.97%-6.07M | -109.26%-64K | -312.87%-4.36M | 68.79%2.43M | -8.26%-4.08M | -922.87%-2.7M | 163.74%691K |
-Change in receivables | 110.22%535K | -211.82%-2.2M | 157.99%2.24M | -77.92%-10.39M | -259.43%-3.26M | -128.40%-5.24M | -19.75%1.97M | 24.03%-3.86M | -963.39%-5.84M | -572.40%-907K |
-Change in inventory | --0 | ---- | ---- | 200.00%75K | --0 | --13K | ---- | ---- | ---75K | ---75K |
-Change in payables and accrued expense | 85.08%1.59M | -398.00%-1.2M | -1,276.74%-2.96M | 31.92%4.24M | 91.03%3.2M | -30.53%858K | 139.55%401K | -116.31%-215K | 266.48%3.21M | 2,290.00%1.67M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 2,188.95%14.94M | -95.79%193K | 24.34%8.81M | -4.51%17.91M | 12.48%6.96M | -112.72%-715K | 36.19%4.59M | 97.55%7.08M | 33.99%18.76M | 443.76%6.19M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 62.35%-1.15M | -341.41%-27.54M | -52.71%-4.99M | 40.44%-19.47M | -20.45%-6.99M | -321.07%-3.06M | -33.86%-6.24M | 84.81%-3.27M | -486.63%-32.7M | -94.24%-5.8M |
Capital expenditure reported | 17.90%-422K | -4.17%-524K | -17.86%-541K | ---- | ---- | ---514K | ---503K | ---459K | ---- | ---- |
Net PPE purchase and sale | -204.44%-274K | -1,550.98%-842K | 52.94%-72K | -36.67%-451K | -885.00%-157K | 16.67%-90K | 48.48%-51K | -6.99%-153K | -8.20%-330K | 125.64%20K |
Net intangibles purchase and sale | ---469K | -16,124.41%-20.61M | --0 | 1.85%-8.79M | -44.30%-8.4M | --0 | 71.59%-127K | 87.19%-265K | -70.01%-8.96M | -100.14%-5.82M |
Net business purchase and sale | --0 | ---- | ---- | 76.26%-5.56M | --0 | ---2.54M | ---- | ---- | ---23.41M | --0 |
Net other investing changes | ---- | ---5.59M | -86.19%-4.45M | ---4.93M | --0 | ---- | --0 | ---2.39M | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 62.35%-1.15M | -341.41%-27.54M | -52.71%-4.99M | 40.44%-19.47M | -20.45%-6.99M | -321.07%-3.06M | -33.86%-6.24M | 84.81%-3.27M | -486.63%-32.7M | -94.24%-5.8M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -13,825.64%-5.43M | 1,188.80%9.72M | -1,297.71%-3.66M | 57.00%-3.14M | 70.33%-1.95M | 89.20%-39K | -620.16%-893K | -2.34%-262K | -120.89%-7.31M | -3,217.68%-6.57M |
Net issuance payments of debt | 6,548.57%6.77M | 19,085.11%17.85M | 4.76%-100K | 93.63%-402K | 98.39%-98K | -40.00%-105K | -18.99%-94K | -22.09%-105K | -2,706.67%-6.32M | -9,104.55%-6.08M |
Net common stock issuance | ---12.45M | -778.26%-6.67M | ---3.08M | -639.08%-2.57M | -420.98%-1.81M | --0 | ---759K | --0 | -100.89%-348K | 87.84%-348K |
Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Proceeds from stock option exercised by employees | 557.55%697K | --451K | --106K | --106K | --0 | --106K | --0 | --0 | --0 | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -13,825.64%-5.43M | 1,188.80%9.72M | -1,297.71%-3.66M | 57.00%-3.14M | 70.33%-1.95M | 89.20%-39K | -620.16%-893K | -2.34%-262K | -120.89%-7.31M | -3,217.68%-6.57M |
Net cash flow | ||||||||||
Beginning cash position | -75.97%7.52M | -24.57%25.32M | -14.28%25.43M | -41.89%29.66M | -23.39%26.88M | 0.67%31.31M | 1.50%33.56M | -41.89%29.66M | 520.63%51.05M | -33.99%35.09M |
Current changes in cash | 319.21%8.35M | -592.57%-17.62M | -95.64%155K | 77.85%-4.71M | 67.99%-1.98M | -184.04%-3.81M | -79.66%-2.54M | 119.55%3.55M | -148.96%-21.25M | -202.00%-6.19M |
Effect of exchange rate changes | 75.00%-154K | -160.48%-176K | -176.66%-266K | 465.89%472K | -30.65%525K | -13.03%-616K | 152.81%291K | 74.37%347K | 78.10%-129K | 1,264.62%757K |
End cash Position | -41.52%15.72M | -75.97%7.52M | -24.57%25.32M | -14.28%25.43M | -14.28%25.43M | -23.39%26.88M | 0.67%31.31M | 1.50%33.56M | -41.89%29.66M | -41.89%29.66M |
Free cash flow | 1,144.05%13.77M | -657.55%-21.78M | 32.04%8.19M | -8.45%8.67M | -131.51%-121K | -126.94%-1.32M | 38.41%3.91M | 351.93%6.21M | 12.39%9.47M | 120.76%384K |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |